Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
| Descriptor ID |
D009169
|
| MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 6 | 0 | 6 |
| 2002 | 1 | 1 | 2 |
| 2003 | 8 | 3 | 11 |
| 2004 | 6 | 2 | 8 |
| 2005 | 9 | 3 | 12 |
| 2006 | 3 | 3 | 6 |
| 2007 | 4 | 2 | 6 |
| 2008 | 3 | 2 | 5 |
| 2009 | 5 | 2 | 7 |
| 2010 | 3 | 3 | 6 |
| 2011 | 12 | 9 | 21 |
| 2012 | 4 | 2 | 6 |
| 2013 | 8 | 0 | 8 |
| 2014 | 6 | 4 | 10 |
| 2015 | 4 | 2 | 6 |
| 2016 | 15 | 8 | 23 |
| 2017 | 11 | 7 | 18 |
| 2018 | 8 | 4 | 12 |
| 2019 | 7 | 6 | 13 |
| 2020 | 11 | 3 | 14 |
| 2021 | 10 | 2 | 12 |
| 2022 | 16 | 0 | 16 |
| 2023 | 5 | 0 | 5 |
| 2024 | 12 | 1 | 13 |
| 2025 | 11 | 5 | 16 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis. Pathogens. 2026 Apr 22; 15(5).
-
Sirtuin2 blockade inhibits replication of human immunodeficiency virus-1 and Mycobacterium tuberculosis in macrophages and humanized mice. Mol Ther. 2026 Jun 03; 34(6):3535-3547.
-
Host- and pathogen-related determinants of pulmonary versus extrapulmonary tuberculosis. Eur Respir Rev. 2026 Jan; 35(179).
-
Noninvasive diagnosis of pulmonary tuberculosis using face mask sampling: a prospective study in adults. Clin Microbiol Infect. 2026 Apr; 32(4):644-649.
-
HIV-associated drug-resistant TB: expanded treatment options and emerging threats. Curr Opin HIV AIDS. 2026 Mar 01; 21(2):172-179.
-
Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiol Spectr. 2026 Jan 06; 14(1):e0233525.
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2025 10 23; 10:CD013359.
-
Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents. Cochrane Database Syst Rev. 2025 07 29; 7:CD009593.
-
Self-powered rapid antigen-specific T-cell response assay for Mycobacterium tuberculosis infections. Nat Biomed Eng. 2026 Jan; 10(1):69-79.
-
Performance of a Novel Stool Quantitative Polymerase Chain Reaction Assay for Pediatric Tuberculosis Detection in Sub-Saharan Africa. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).